Evidence map›Paper›PMID 33229544›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

ATP13A2-mediated endo-lysosomal polyamine export counters mitochondrial oxidative stress.

Stephanie Vrijsen, Laura Besora-Casals, Sarah van Veen, Jeffrey Zielich, Chris Van den Haute, Norin Nabil Hamouda, Christian Fischer, Bart Ghesquière, Ivailo Tournev, Patrizia Agostinis and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 1 pooled it
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 1 synthesis or guideline pooled it, 102 citations in OpenAlex.

  1. Pooled it
  2. Functional Characterization of the P-Type ATPases ATP13A3 and ATP13A4 as Plasma Membrane Polyamine Transporters.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Serum L-ornithine-derived polyamines as indicators of Parkinson disease progression.Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Article
  8. Review
  9. Review
  10. ATP13A2 restrains macrophage NLRP3 inflammasome activation to repress neurodegeneration via modulating mitochondrial homeostasis.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  11. Article
  12. Article
  13. Polyamine Metabolism in Brain Health and Disease.Neuropharmacology and therapy · 2026
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Mitochondrial Dysfunction in Genetic and Non-Genetic Parkinson's Disease.International journal of molecular sciences · 2025
    Review
  20. Rescue of a Rotenone Model of Parkinson's Disease inInternational journal of molecular sciences · 2025
    Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 4 countries.

Stephanie VrijsenLaboratory of Cellular Transport Systems, Department of Cellular and Molecular Medicine, Katholieke Universiteit Leuven (KU Leuven), 3000 Leuven, Belgium.ORCID 0000-0002-2601-510X
Laura Besora-CasalsCell and Developmental Biology, Department Biology II, Ludwig Maximilians Universität, 80539 Münich, Germany.ORCID 0000-0001-5113-957X
Sarah van VeenLaboratory of Cellular Transport Systems, Department of Cellular and Molecular Medicine, Katholieke Universiteit Leuven (KU Leuven), 3000 Leuven, Belgium.ORCID 0000-0002-7639-7847
Jeffrey ZielichCell and Developmental Biology, Department Biology II, Ludwig Maximilians Universität, 80539 Münich, Germany.ORCID 0000-0003-4879-0649
Chris Van den HauteLaboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, 3000 Leuven, Belgium.
Norin Nabil HamoudaLaboratory of Cellular Transport Systems, Department of Cellular and Molecular Medicine, Katholieke Universiteit Leuven (KU Leuven), 3000 Leuven, Belgium.
Christian FischerCell and Developmental Biology, Department Biology II, Ludwig Maximilians Universität, 80539 Münich, Germany.
Bart GhesquièreMetabolomics Expertise Center, Vlaams Instituut voor Biotechnologie (VIB)-KU Leuven Center for Cancer Biology, Department of Oncology, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0003-1547-1705
Ivailo TournevDepartment of Neurology, Medical University-Sofia, 1431 Sofia, Bulgaria.
Patrizia AgostinisLaboratory of Cell Death Research and Therapy, VIB-KU Leuven Center for Cancer Biology, Department of Cellular and Molecular Medicine, KU Leuven, 3000 Leuven, Belgium.
Veerle BaekelandtLaboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, 3000 Leuven, Belgium.
Jan EggermontLaboratory of Cellular Transport Systems, Department of Cellular and Molecular Medicine, Katholieke Universiteit Leuven (KU Leuven), 3000 Leuven, Belgium.ORCID 0000-0002-8497-1159
Eric LambieCell and Developmental Biology, Department Biology II, Ludwig Maximilians Universität, 80539 Münich, Germany.ORCID 0000-0002-7371-128X
Shaun MartinLaboratory of Cellular Transport Systems, Department of Cellular and Molecular Medicine, Katholieke Universiteit Leuven (KU Leuven), 3000 Leuven, Belgium.
Peter VangheluweLaboratory of Cellular Transport Systems, Department of Cellular and Molecular Medicine, Katholieke Universiteit Leuven (KU Leuven), 3000 Leuven, Belgium; peter.vangheluwe@kuleuven.be.ORCID 0000-0002-7822-2944
KU Leuven · BELudwig-Maximilians-Universität München · DECenter for Integrated Protein Science Munich · DEMedical University of Sofia · BGUniversity College London · GBVIB-KU Leuven Center for Cancer Biology · BEVlaams Instituut voor Biotechnologie · BE

Funding

Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Aric L Daul, Ann E. Rougvie · 2012 to 2026
$7.5M
NIH HHS P40 OD010440
6 · The paper itself

Abstract

Recessive loss-of-function mutations in

Indexed as

Activating Transcription Factor 4Adenosine TriphosphatasesAnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsEflornithineFibroblastsLysosomesMitochondriaMutationOxidative StressParkinson DiseasePolyaminesProton-Translocating ATPasesRotenoneSpermineActivating Transcription Factor 4Adenosine TriphosphatasesATF4 protein, humanATFS-1 protein, C elegansATP13A2 protein, humanCaenorhabditis elegans ProteinsCATP-6 protein, C elegansDDIT3 protein, humanEflornithinePolyaminesProton-Translocating ATPasesRotenoneSpermineTranscription Factor CHOPTranscription FactorsantioxidantmitochondrianeurodegenerationP5B-type ATPasepolyamine transport

Identifiers

PMID33229544
PMCPMC7733819
OpenAlexW3110543229

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.